Fig. 1From: Effects of tapering tumor necrosis factor inhibitor on the achievement of inactive disease in patients with axial spondyloarthritis: a nationwide cohort studyLikelihood of achieving a ASDAS-inactive disease and b BASDAI50 response in the 1-year interval among the three groups during observation. ASDAS, Ankylosing Spondylitis Disease Activity Score; axSpA, axial spondyloarthritis; BASDAI, Bath Ankylosing Spondylitis Disease Activity IndexBack to article page